Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor

Clinical trial NCT03603678 · COMPLETED

Trial details

NCT number: NCT03603678
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Apnea, Obstructive

Start date: 2018-08-13
Primary completion: 2019-05-23
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.